CORT:NASDAQ
Corcept Therapeutics Inc
$72.94
arrow_downward
-1.04%(-0.77) 1D
$72.94
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CORT...
Open
$73.87
High
$74.68
Low
$71.18
Mkt. cap
7.98B
Avg. vol.
1.09M
Volume
1.11M
P/E ratio
57.35
52-wk high
$126.38
52-wk low
$28.66
EPS
$1.27
Beta
0.54
Shares outstanding
109.44M
No. of employees
730
Open
$73.87
High
$74.68
Low
$71.18
Mkt. cap
7.98B
Avg. vol.
1.09M
Volume
1.11M
P/E ratio
57.35
52-wk high
$126.38
52-wk low
$28.66
EPS
$1.27
Beta
0.54
Shares outstanding
109.44M
No. of employees
730
News stories
From web sources and news partners
ING Sprinters
·
2 days ago
De AEX Index blijft voortmodderen
Nieuws.nl
·
22 hours ago
AEX-index lager door onrust rond Nvidia
Profile
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
About Corcept Therapeutics Inc
CEO-
Employees730
FoundedMay 13, 1998
HeadquartersMenlo Park, California, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitecorcept.com